Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)
Silvia Messina(University of Oxford), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Daniele Spitaleri(Azienda Ospedaliera S.Giuseppe Moscati), Letizia Castelli(Multiple Sclerosis Foundation), Massimiliano Mirabella(Università Cattolica del Sacro Cuore), Claudio Gasperini(Nini Hospital), Ada Francia(Sapienza University of Rome), Elisabetta Signoriello(ATS Sardegna (Italy)), Loredana Petrucci(University of Pisa), Isabella Righini, Mario Zappia(University of Catania), Alberto Gajofatto(University of Verona), Gianfranco Costantino(Ospedali Riuniti di Foggia), Roberto Bruno Bossio(Azienda Ospedaliera di Cosenza), Marco Rovaris(San Raffaele University of Rome), Simona Bonavita, Damiano Paolicelli(University of Bari Aldo Moro), Paola Cavalla, Graziella Pedà(Multiple Sclerosis Foundation), Edoardo Sessa(Centro Neurolesi Bonino Pulejo), Alfredo Granata(Magna Graecia University), Francesco Patti(University of Catania), Manuela Matta(Ospedale San Luigi Gonzaga), Gabriella Spinicci(University of Cagliari), Claudio Solaro(Rina Services (Italy)), Vincenzo Brescia Morra(Federico II University Hospital), Giorgia Teresa Maniscalco(Ospedale Antonio Cardarelli), Giancarlo Comi(Vita-Salute San Raffaele University), Salvatore Cottone, Diego Centonze(University of Rome Tor Vergata), Maura Danni(Multiple Sclerosis Foundation)
Cited by 58
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k